Live Breaking News & Updates on Silence therapeutics company profile

Stay informed with the latest breaking news from Silence therapeutics company profile on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Silence therapeutics company profile and stay connected to the pulse of your community

Short Interest in Silence Therapeutics plc (NASDAQ:SLN) Rises By 74.8%

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 162,000 shares, an increase of 74.8% from the March 15th total of 92,700 shares. Based on an average trading volume of 241,700 shares, the short-interest ratio […]

Nasdaq , Parkman-healthcare-partners , Goldman-sachs-group-inc , Silence-therapeutics-company-profile , Morgan-stanley , Vivo-capital , Silence-therapeutics , Get-free-report , Sachs-group , Healthcare-partners , Therapeutics-trading-down

Silence Therapeutics (NASDAQ:SLN) Receives "Buy" Rating from HC Wainwright

Silence Therapeutics (NASDAQ:SLN) Receives "Buy" Rating from HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Artal-group , Lombard-odier-asset-management-united-states-corp , Goldman-sachs-group-inc , Silence-therapeutics-company-profile , Lombard-odier-asset-management-europe-ltd , Vivo-capital , Nasdaq , Silence-therapeutics , Free-report , Odier-asset-management-united-states-corp , Odier-asset-management-europe-ltd

Silence Therapeutics (OTCMKTS:SLNCF) Stock Price Up 30%

Shares of Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) shot up 30% during trading on Wednesday . The stock traded as high as $3.25 and last traded at $3.25. 500 shares were traded during trading, a decline of 6% from the average session volume of 533 shares. The stock had previously closed at $2.50. […]

Silence-therapeutics-company-profile , Silence-therapeutics , Get-free-report , Oligonucleotide-discovery , Silence-therapeutics-daily , Otcmkts-slncf , Slncf , Medical , Stocks , Technicals ,

Silence Therapeutics (NASDAQ:SLN) Shares Up 5.3%

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report)’s stock price rose 5.3% during trading on Tuesday . The stock traded as high as $23.88 and last traded at $23.35. Approximately 80,500 shares traded hands during trading, a decline of 68% from the average daily volume of 251,028 shares. The stock had previously closed at $22.17. […]

Cantor-fitzgerald , Silence-therapeutics-company-profile , Geode-capital-management , Schonfeld-strategic-advisors , Millennium-management , Nasdaq , Silence-therapeutics , Get-free-report , Capital-management , Strategic-advisors , Oligonucleotide-discovery , Silence-therapeutics-daily

Silence Therapeutics (NASDAQ:SLN) Receives "Buy" Rating from HC Wainwright

Silence Therapeutics (NASDAQ:SLN) Receives "Buy" Rating from HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cantor-fitzgerald , Silence-therapeutics-company-profile , Sg-americas-securities , Schonfeld-strategic-advisors , Silence-therapeutics , Free-report , Get-free-report , Strategic-advisors , Oligonucleotide-discovery , Silence-therapeutics-daily ,

Silence Therapeutics (LON:SLN) Stock Price Crosses Below Two Hundred Day Moving Average of $535.00

Silence Therapeutics plc (LON:SLN – Get Free Report)’s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 535 ($6.53) and traded as low as GBX 512 ($6.25). Silence Therapeutics shares last traded at GBX 535 ($6.53), with a volume of 913,528 shares. […]

Silence-therapeutics-company-profile , Silence-therapeutics , Get-free-report , Oligonucleotide-discovery , Silence-therapeutics-daily , Lon-sln , Sln , Medical , Stocks , Technicals ,

Silence Therapeutics (OTCMKTS:SLNCF) Trading 59% Higher

Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s stock price traded up 59% during trading on Thursday . The company traded as high as $0.95 and last traded at $0.95. 141 shares were traded during trading, a decline of 96% from the average session volume of 3,377 shares. The stock had previously closed at $0.60. […]

Silence-therapeutics-company-profile , Silence-therapeutics , Get-free-report , Therapeutics-stock-down , Oligonucleotide-discovery , Silence-therapeutics-daily , Otcmkts-slncf , Slncf , Medical , Stocks , Technicals

Silence Therapeutics (OTCMKTS:SLNCF) Trading Up 59%

Shares of Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) were up 59% during mid-day trading on Thursday . The company traded as high as $0.95 and last traded at $0.95. Approximately 141 shares were traded during trading, a decline of 96% from the average daily volume of 3,377 shares. The stock had previously closed […]

Silence-therapeutics-company-profile , Silence-therapeutics , Get-free-report , Therapeutics-trading-down , Oligonucleotide-discovery , Silence-therapeutics-daily , Otcmkts-slncf , Slncf , Medical , Stocks , Technicals

Silence Therapeutics (NASDAQ:SLN) Rating Reiterated by HC Wainwright

Silence Therapeutics (NASDAQ:SLN) Rating Reiterated by HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cantor-fitzgerald , Silence-therapeutics-company-profile , Morgan-stanley , Citadel-advisors , Millennium-management , Geode-capital-management , Schonfeld-strategic-advisors , Silence-therapeutics , Free-report , Strategic-advisors , Capital-management , Get-free-report

Chardan Capital Reiterates "Buy" Rating for Silence Therapeutics (NASDAQ:SLN)

Chardan Capital restated their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a report released on Thursday morning, Benzinga reports. The firm currently has a $26.00 target price on the stock. Separately, Morgan Stanley restated an overweight rating and issued a $20.00 target price on shares of Silence Therapeutics in a […]

Cantor-fitzgerald , Morgan-stanley , Millennium-management , Silence-therapeutics-company-profile , Schonfeld-strategic-advisors , Geode-capital-management , Chardan-capital , Silence-therapeutics , Free-report , Get-free-report , Capital-management , Strategic-advisors